Cyclic Poly L-Latic Acid

US 10,954,336, assigned to Scrum Co, covers a cyclic poly L-lactic acid (composition) having a specific pH by the polymer itself (alone), a method for producing the same, a pharmaceutical product containing the cyclic poly L-lactic acid (composition) and the like, and is available for sale through IPApproach.

US Patents

1 granted

Assignee

Scrum Co

Availability

For Sale

Patents Included

• US 10,954,336↗

Technology Highlights

• The invention substance is a kind of a regulatory substance secreted from the cell, which is taken into the body and involved in the improvement of cell functions.
• The invention substance has various medical uses such as a metabolic regulator, a metabolic inhibitor, an immune activator (for example, activator of immune cells such as NK cells), an inhibitor of LDH activity of a cancer cell, an inhibitor/suppressor of the growth of a cancer cell and a cancer therapeutic agent.
• The invention substance is a biodegradable and bio-absorbable substance, and is involved in the generation of intracellular energy in the body.
• The invention substance has a low molecular weight of 2,000 or less, and is used in pharmaceuticals, foods, drinking water, and health foods.
• The invention substance can be administrated orally as oral powder, tablets, capsules, and parenterally drops, injections, poultices, and the like.
• The invention substance does not have acidity therefore it does not require a neutralizing agent or sweetener, and is easy to process and to ingest.

Overview

IPApproach, LLC is pleased to present the exclusive patent for sale "Cyclic poly L-lactic acid" which includes U.S. Granted Patent US 10,954,336 B2 assigned to SCRUM Co. Ltd. The IP relates to a cyclic poly L-lactic acid (composition) having a specific pH by the polymer itself (alone), a method for producing the same, a pharmaceutical product containing the cyclic poly L-lactic acid (composition) and the like.

The technology disclosed provides the following advantages:

Listing updated August 21, 2026

IPApproach lists patents and portfolios where the seller has not requested anonymity or confidentiality. Patent numbers link to public records on Google Patents.